Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation [Phase 1]
A Phase 1 trial evaluating Velcade (bortezomib) and lenalidomide in patients with relapsed myelodysplastic syndrome or acute myeloid leukemi…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies [Phase 1]
A Phase 1 study evaluating CG009301 for injection in adults with recurrent or refractory hematologic malignancies; recruitment is ongoing fo…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS [Phase 1]
Phase 1 clinical trial of CD64 CAR T cell therapy for adults with relapsed/refractory AML or high-risk MDS. The trial status is not yet recr…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial [EARLY_Phase 1]
This update describes an early-phase dose-escalation trial evaluating CART123 T cells in relapsed or refractory CD123+ hematologic malignanc…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome [Phase 1, Phase 2]
A Phase 1/2 clinical trial at MD Anderson evaluating a triple combination of Quizartinib, Decitabine, and Venetoclax for untreated or relaps…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells [Phase 2]
This Phase 2 clinical trial evaluates allogeneic hematopoietic stem cell transplantation using G-CSF mobilized CD34+ selected cells co-infus…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating palifermin in combination with leuprolide acetate to promote immune recovery after total body irradiation-…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Efficacy and Safety of HMAs Combined With Venetoclax Versus HMAs Alone in ND Int-and H-risk MDS or CMML
This clinical trial update covers the efficacy and safety of combining hypomethylating agents with venetoclax versus hypomethylating agents …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation [NA]
A clinical trial is evaluating the safety and feasibility of sulforaphane to promote early hematopoietic recovery after cord blood transplan…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN [Phase 1]
This Phase 1 trial update reports adding venetoclax to fludarabine and busulfan conditioning before transplant and to maintenance therapy fo…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome [Phase 3]
A Phase 3 clinical trial comparing mismatched related donor versus matched unrelated donor stem cell transplantation in children, adolescent…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes [Phase 2]
Phase 2 trial evaluating adding pomalidomide to the standard liposomal daunorubicin/cytarabine chemotherapy in newly diagnosed acute myeloid…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Off-the-shelf NK Cells + SCT for Myeloid Malignancies [Phase 2]
Phase 2 trial evaluating off-the-shelf natural killer (NK) cells in combination with stem cell transplantation for myeloid malignancies has …
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia [Phase 1, Phase 2]
Clinical trial update for 211At-BC8-B10 given before donor stem cell transplant in high-risk acute myeloid leukemia, acute lymphoblastic leu…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies [Phase 1, Phase 2]
A Phase 1/2 study is evaluating CCS1477 (Inobrodib) in multiple hematologic malignancies and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cytokine-treated veto cells as an adoptive therapy after stem cell transplantation for various hematolog…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Safety of MT-401-OTS in Patients With Relapsed AML or MDS [Phase 1]
A Phase 1 clinical trial update assessing the safety of MT-401-OTS in patients with relapsed acute myeloid leukemia or myelodysplastic syndr…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia
An update on a clinical trial evaluating natural killer cell therapy for monitoring patients with acute myeloid leukemia, acute lymphoblasti…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS [Phase 1, Phase 2]
This document reports an ongoing Phase 1/Phase 2 clinical trial of ARD103 CAR-T therapy for relapsed/refractory acute myeloid leukemia and m…
-
CLINICAL_TRIALS other · 2025-12-10Clinical Trial Update: Momelotinib in VEXAS Syndrome [Phase 2]
A Phase 2 clinical trial evaluating momelotinib for VEXAS syndrome is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
This document reports a long-term follow-up study of patients treated with ARD103 CAR-T cell therapy for acute myeloid leukemia (relapsed or…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene. [NA]
A clinical trial update describing families with a hematopathy predisposition related to the DDX41 gene mutation. The study is currently rec…
-
CLINICAL_TRIALS other · 2025-12-08Clinical Trial Update: Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome [Phase 1]
Navitoclax is being studied in a Phase 1 trial for relapsed or refractory high-risk myelodysplastic syndrome, with the study currently liste…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan
This clinical trial entry notes a recruiting study in Japan evaluating patient-reported outcomes and patient perspectives in individuals wit…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome [Phase 1]
A Phase 1 clinical trial evaluating ASTX030 in patients with myelodysplastic syndrome is currently recruiting.